Parallax Volatility Advisers
AMED

Parallax Volatility Advisers’s Amedisys AMED Stock Holding History

Parallax Volatility Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,235
Closed -$1.24M – 3212
2020
Q4 		$1.24M Buy
+4,235
New +$1.09M ﹤0.01% 2088
2019
Q2 		– Sell
-22
Closed -$3K – 2508
2019
Q1 		$3K Buy
+22
New +$2.76K ﹤0.01% 2599
2018
Q4 		– Sell
-17
Closed -$2K – 2874
2018
Q3 		$2K Sell
17
-3
-15% -$331 ﹤0.01% 2407
2018
Q2 		$2K Buy
+20
New +$1.47K ﹤0.01% 1918
2018
Q1 		– Sell
-4,368
Closed -$230K – 2197
2017
Q4 		$230K Buy
+4,368
New +$230K ﹤0.01% 2171

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Parallax Volatility Advisers's AMED Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of Amedisys (AMED) in Q1 2021, closing a stake of 4,235 shares — an estimated $1.24M sold.

Parallax Volatility Advisers first reported a position in AMED in Q4 2017 and held it in 5 quarters. The position peaked at $1.24M in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,235 Amedisys shares in Q1 2021, an estimated $1.24M.
  • Parallax Volatility Advisers first reported a position in Amedisys in Q4 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Amedisys position peaked at $1.24M in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.